Resources

/Resources
Resources 2021-04-28T14:16:20-04:00

RESOURCES

Browse our Resources

Use the below filters and search to find publications including Amicus Briefs, Testimony and Comments, IPO Law Journal Articles, and the IPO Federal Circuit Summaries™.

TITLE PUBLISHED CATEGORY
CLAIMS FOR TYPE 2 DIABETES TREATMENT WERE NOT ANTICIPATED* * Mylan Pharm. Inc. v. Merck Sharp & Dohme Corp., 21-2121 September 29, 2022 IPO Federal Circuit Summaries
PLAUSIBLE CLAIM OF INVENTIVENESS SUFFICIENT TO OVERCOME MOTION TO DISMISS AS PATENT INELIGIBLE* * Cooperative Entertainment, Inc. v. Kollective Technology, Inc., 21-2167 September 28, 2022 IPO Federal Circuit Summaries
FEDERAL CIRCUIT VACATES IPR DECISION BASED ON INSUFFICIENT PATENTABILITY ANALYSIS* * Provisur Technologies, Inc. v. Weber, Inc., 21-1942 September 27, 2022 IPO Federal Circuit Summaries
IPO Conversations with Leaders September 16, 2022 IPO Law Journal
USPTO DENIAL OF MOTION TO TERMINATE DID NOT VIOLATE APA* * Polaris Innovations Ltd. v. Brent, 19-1483 September 15, 2022 IPO Federal Circuit Summaries
NO PATENT TERM ADJUSTMENT FOR APPEALS THAT DID NOT REVERSE ADVERSE DETERMINATIONS OF UNPATENTABILITY* * Sawstop Holding LLC v. Vidal, 21-1537 September 14, 2022 IPO Federal Circuit Summaries
IPOwners Quarterly™ 6/30/2022 September 08, 2022 IPOwners Quarterly
RESTRICTION REQUIREMENT FOR HYATT’S CLAIMS WAS PROPER UNDER APPLICANT-ACTION EXCEPTION* * Hyatt v. PTO, 21-2324 September 08, 2022 IPO Federal Circuit Summaries
FEDERAL CIRCUIT UPHOLDS DISMISSAL OF PATENT INFRINGEMENT COMPLAINT UNDER DUPLICATIVE-LITIGATION DOCTRINE* * Arendi S.A.R.L. v. LG Electronics Inc., 21-1967 September 07, 2022 IPO Federal Circuit Summaries
FEDERAL CIRCUIT UPHOLDS ITC DETERMINATION OF NO SECTION 337 VIOLATION* * INVT SPE LLC v. ITC, 20-1903 August 31, 2022 IPO Federal Circuit Summaries
PATENT OWNER LACKED STANDING TO APPEAL IPR DECISION CONCERNING CLAIM FINALLY CANCELED BEFORE APPEAL WAS FILED* * Best Medical Int’l, Inc. v. Elekta Inc., 21-2099 August 29, 2022 IPO Federal Circuit Summaries
FEDERAL CIRCUIT UPHOLDS REJECTION OF CLAIMS AS PATENT-INELIGIBLE ABSTRACT IDEA* * In Re Killian, 21-2113 August 23, 2022 IPO Federal Circuit Summaries
ANDA SPECIFICATION CONTROLS AND DEFINES A NON-INFRINGING PRODUCT UNDER SECTION 271(E)(2)* Par Pharm., Inc. v. Eagle Pharm., Inc., 21-2342 August 18, 2022 IPO Federal Circuit Summaries
IPR ESTOPPEL APPLIED TO NON-INSTITUTED CLAIM WHERE PETITIONER DID NOT SEEK REMAND TO ADDRESS ALL CLAIMS POST-SAS* * Click-to-Call Technologies, LP v. Ingenio, Inc., 22-1016 August 17, 2022 IPO Federal Circuit Summaries
USPTO POLICY REFUSING REQUESTS FOR DIRECTOR REVIEW OF NON-INSTITUTION DECISIONS DOES NOT VIOLATE APPOINTMENTS CLAUSE* * In Re Palo Alto Networks, Inc., 22-145 August 16, 2022 IPO Federal Circuit Summaries
USPTO CORRECTLY CONSTRUED PRODUCT-BY-PROCESS CLAIM ELEMENT* Kamstrup A/S v. Axioma Metering UAB, 21-1923 August 12, 2022 IPO Federal Circuit Summaries
ON REMAND FROM U.S. SUPREME COURT, FEDERAL CIRCUIT REAFFIRMS THAT ASSIGNOR ESTOPPEL BARRED PATENT VALIDITY CHALLENGE* * Hologic, Inc. v. Minerva Surgical, Inc., 19-2054 August 11, 2022 IPO Federal Circuit Summaries
REFERENCE WAS NOT PRIOR ART BECAUSE IT WAS NOT “BY ANOTHER”* LSI Corp. v. Regents of the Univ. of Minnesota, 21-2057 August 11, 2022 IPO Federal Circuit Summaries
REISSUE PATENT CLAIMS RECAPTURED SUBJECT MATTER SURRENDERED IN ORIGINAL PROSECUTION* * In Re McDonald, 21-1697 August 10, 2022 IPO Federal Circuit Summaries
The Myth of the Meritocracy in Law Firms and Corporate Legal Departments August 09, 2022 IPO Law Journal
ONLY HUMANS MAY BE NAMED INVENTORS ON U.S. PATENTS* * * Thaler v. Vidal, 21-2347 August 05, 2022 IPO Federal Circuit Summaries
IPO Letter to Senator Tillis re: Introduction of Patent Eligibility Restoration Act of 2022 August 03, 2022 Testimony and Comments
IPO/AIPLA Category Definitions for AI-Related Inventions August 01, 2022 Testimony and Comments
IPO Amicus Brief in European Patent Office, Enlarged Board of Appeal G1/22 & 2/22 July 29, 2022 Amicus Briefs
FEDERAL CIRCUIT UPHOLDS DISTRICT COURT’S AWARD OF ATTORNEY FEES* * Realtime Adaptive Streaming v. Netflix, Inc., 21-1484 July 27, 2022 IPO Federal Circuit Summaries
DIAGNOSTIC METHOD FOR PREDICTING ORGAN TRANSPLANT REJECTION WAS PATENT-INELIGIBLE* * CareDX, Inc. v. Natera, Inc., 2022-1027 July 18, 2022 IPO Federal Circuit Summaries
Resolution Relating to Transparency of Decisions July 14, 2022 Board Resolutions
COURT UPHOLDS DENIAL OF PRELIMINARY INJUNCTION BARRING ITC ACTION ON ALLEGED STANDARD ESSENTIAL PATENTS* * Koninklijke Philips N.V. v. Thales USA, Inc., 21-2106 July 13, 2022 IPO Federal Circuit Summaries
IPO Response to Request for Information to Make Access to the Innovation Ecosystem More Inclusive and Equitable July 11, 2022 Testimony and Comments
PATENT DISCLOSURE WAS NOT PRIOR ART DUE TO OBVIOUS ERROR* * LG Electronics Inc. v. ImmerVision, Inc., 21-2037 July 11, 2022 IPO Federal Circuit Summaries
“Unofficial” CN Orange Book User Guide for Pharmaceutical Patents June 30, 2022 IPO Law Journal
NO STATUTORY CAUSE OF ACTION TO CHALLENGE TRADEMARK REGISTRATIONS ABSENT LOST SALES OR REPUTATIONAL INJURY IN U.S.* * Meenaxi Enterprise, Inc. v. The Coca-Cola Co., 21-2209 June 29, 2022 IPO Federal Circuit Summaries
FEDERAL CIRCUIT OVERTURNS CONTEMPT ORDER IN DESIGN PATENT CASE* Static Media LLC v. Leader Accessories LLC, 21-2303 June 28, 2022 IPO Federal Circuit Summaries
IPO and Other Associations Joint Statement on WTO Decision to Change IP Framework June 23, 2022 Testimony and Comments
Chief IP Counsel in a Box Toolkit June 23, 2022 IPO Law Journal
WILLFUL INFRINGEMENT VERDICT VACATED TO REMEDY TRIAL JUDGE’S FAILURE TO RECUSE HIMSELF UPON LEARNING WIFE OWNED STOCK IN A PARTY* * * Centripetal Networks, Inc. v. Cisco Systems, Inc., 21-1888 June 23, 2022 IPO Federal Circuit Summaries
ON REHEARING, FEDERAL CIRCUIT VACATES DECISION UPHOLDING CLAIMS AS MEETING WRITTEN DESCRIPTION REQUIREMENT* * Novartis Pharm. v. Accord Healthcare Inc., 21, 1070 June 21, 2022 IPO Federal Circuit Summaries
FEDERAL CIRCUIT VACATES INDEFINITENESS RULING PREMISED ON FLAWED CLAIM CONSTRUCTION* * University of Massachusetts v. L’Oreal S.A., 21-1969 June 13, 2022 IPO Federal Circuit Summaries
IPO Comments to the China National Medical Products Administration Re: Feedback on the Regulations for the Implementation of the Drug Administration Law of the People’s Republic of China June 09, 2022 Testimony and Comments
FEDERAL CIRCUIT UPHOLDS DISTRICT COURT CORRECTION OF “OBVIOUS CLERICAL ERROR” IN CLAIM* * Federal Circuit Upholds District Court Correction of “Obvious Clerical Error” in Claim June 03, 2022 IPO Federal Circuit Summaries
Load More